BOSTON--(BUSINESS WIRE)--T1D Exchange today announced that it will share data from ten abstracts, including six late breaking, focused on quality improvement, population health and real-world evidence and outcomes of people living with type 1 diabetes (T1D) at the American Diabetes Association (ADA) 80th Scientific Virtual Sessions. Two posters from the organization’s Quality Improvement Collaborative were recognized by healthcare information firm Close Concerns in its list of Top 50 Most Notable Posters.
“Following our recent evidence published in Diabetes Care on COVID-19 and T1D, we are excited to present additional compelling real-world evidence at ADA,” said David Walton, CEO of T1D Exchange. “From fear of hypoglycemia, to characteristics of CGM users, to inequities in health outcomes, we are proud of both the volume and diversity of abstract topics being presented.”
The ten abstracts being presented include findings and data from T1D Exchange’s Quality Improvement Collaborative, Online Registry and Outcomes Research teams.
“The Quality Improvement Collaborative was created to redefine best practices, enhance the quality of care and generate better outcomes for people living with type 1 diabetes. We are thrilled that our presentations have been recognized for their significance by the diabetes community,” said Osagie Ebekozien, Vice President of Population Health and Quality Improvement at T1D Exchange.
Quality Improvement Collaborative Study Highlights
Title: Improving Continuous Glucose Monitoring (CGM) Use Across National Centers: Results from the T1D Exchange Quality Improvement Collaborative (T1DX-QI)
Date: Saturday, June 13, 2020
Late Breaking Poster Session, Close Concerns Closer Look Notable Poster
Summary: While many studies have demonstrated the clinical benefit of the use of CGMs in T1D, and favorable insurance policy changes have gradually increased the access of CGMs nationally, widespread uptake has been slow. This study reports how ten diabetes centers used QI principles to test and expand different interventions to increase CGM use in their respective centers. Results demonstrate that by using QI principles to test interventions and cross-learning, the T1D community can increase the use of CGM devices.
Title: Increasing Insulin Pump Use across Five National Diabetes Centers: Results from the T1D Exchange Quality Improvement Collaborative
Date: Saturday, June 13, 2020
Late Breaking Poster Session, Close Concerns Closer Look Notable Poster
Summary: Several research studies have demonstrated the impact of insulin pump use and frequent insulin bolusing on diabetes-related clinical outcomes. Five centers used QI methodology to test and expand insulin pump use initiatives among patients aged 12 - 26 years. Successful interventions include developing mobile technology classes, redesigning workflow, coaching patients to bolus for meals and corrections, and removing barriers to adoption.
The centers shared data monthly with the coordinating office, and the data were used for ongoing QI coaching and to promote the cross-sharing of best practices. Results showed that successful QI interventions improved pump use.
Additional posters being presented on June 13, 2020, include:
- Emotional Impact of Hypoglycemia and Use of Glucagon: Perspectives of People with T1D and Caregivers of Minors with T1D, Late Breaking Poster Session
- “You Don’t Know When the Sugar’s Going to Kick In”: Experiences of People Managing Type 1 Diabetes during a Marathon, Late Breaking Poster Session
- Development of a Fear of Hypoglycemia Screener: Type 1 Diabetes Health Care Provider Insight
- Moving the Needle on the High-Risk T1D Panel: Lessons from the T1D Exchange Quality Improvement Collaborative (T1DX-QI) – Late Breaking Poster Session
- Inequities in Health Outcomes Among Patients in the T1DX-QI Collaborative
- Reducing Lost to Follow-Up Rates in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)
- T1D Exchange Registry: Current Data Insights and Future Impact, Late Breaking Poster Session
- Patient Demographics and Clinical Outcomes among Type 1 Diabetes (T1D) Patients Using Continuous Glucose Monitors (CGMs): A Study from the Largest Cohort of T1D Patients in the U.S.
Follow T1D Exchange on Twitter via @T1DExchange and use the hashtag #ADA2020 for additional news and updates.
About T1D Exchange
T1D Exchange is a leading provider of real-world evidence, dedicated to improving outcomes for the entire T1D population through driving collaborative change. T1D Exchange actively supports quality improvement and innovation through its Quality Improvement Collaborative, patient registry, and data-oriented research services. It plays an active role in creating real-world impact with this integrated data by providing clinicians, researchers, industry partners and advocates with the resources and services they need for better decision support and population health management.
T1D Exchange was established ten years ago with ongoing support from The Leona M. and Harry B. Helmsley Charitable Trust.
